How AI is improving cancer diagnostics
(Neil Savage/ Nature) — When a young girl came to New York University (NYU) Langone Health for a routine follow-up, tests seemed to show that the medulloblastoma for which she had been treated a few years earlier had returned. The girl’s recurrent cancer was found in the same part of brain as before, and the biopsy seemed to confirm medulloblastoma.
With this diagnosis, the girl would begin a specific course of radiotherapy and chemotherapy. But just as neuropathologist Matija Snuderl was about to sign off on the diagnosis and set her on that treatment path, he hesitated. The biopsy was slightly unusual, he thought, and he remembered a previous case in which what was thought to be medulloblastoma turned out to be something else. So, to help him make up his mind, Snuderl turned to a computer.
He arranged for the girl to have a full-genome methylation analysis, which checks for small hydrocarbon molecules attached to DNA. The addition of such methyl groups is one of the mechanisms behind epigenetics — when the activity of genes is altered without any mutation to the underlying genetic code — and different types of cancer show different patterns of methylation. Snuderl fed the results to an artificial-intelligence (AI) system developed by a consortium including researchers at the German Cancer Research Center in Heidelberg, and let the computer classify the tumour.
“The tumour came back as a glioblastoma, which is a completely different type,” Snuderl says. The new tumour seemed to be the result of radiation used to destroy the first cancer, and called for a different drug and radiation treatment plan. Treatment for the wrong cancer could have ill effects without actually destroying the cancer. “If I had finalized the case just on pathology, I would have been terribly wrong,” Snuderl says. (…)read full story